The Georgia Research Alliance (GRA) expands research and commercialization capacity in Georgia’s universities to launch new companies,
Business Model:
Revenue: $500M
Employees: 51-200
Address: 270 Peachtree Street NW
City: Atlanta
State: GA
Zip: 30303
Country: US
The Georgia Research Alliance (GRA) expands research and commercialization capacity in Georgia’s universities to launch new companies, create high-value jobs and transform lives. Since its formation in 1990, GRA has leveraged over $600 million of state funding into: $2.6 billion of direct federal and private investment in Georgia 150+ newly launched companies 6,000+ high-skill, high-value jobs a portfolio of inventions, processes and technologies that benefit humankind GRA is an independent nonprofit (501c3) organization closely aligned with Georgia’s Department of Economic Development and works with the following partner universities: University of Georgia, Georgia Regents University, Emory University, Clark Atlanta University, Georgia Institute of Technology, Georgia State University, Mercer University and Morehouse School of Medicine.
Contact Phone:
+14043329770
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2006 | Velocity Medical Solutions | Grant | 25k |
11/2017 | Centizyme | Grant | 10k |
2/2017 | Sophia Bioscience | Grant | 59.2k |
7/2017 | RePredix | Grant | 25k |
8/2019 | Pyrefin | Grant | 52.6k |
8/2019 | Proxime | Grant | 40.1k |
2/2018 | Proxime | Grant | 27k |
4/2018 | BioPace | Grant | 54.5k |
2/2019 | Aviabiotic | Grant | 30k |
11/2019 | PNP Therapeutics | Grant | 50k |
11/2011 | Metaclipse Therapeutics | Grant | 25k |
3/2014 | AngioCloud | Grant | 54.4k |
2/2020 | Focused Cryo | Grant | 0 |
3/2020 | Neovaccine Strategies | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
9/2016 | Nyra Medical | Grant | 74.9k |
1/2020 | Nyra Medical | Grant | 0 |
2/2018 | Oncospherix | Grant | 22.4k |
4/2019 | Oncospherix | Grant | 41.6k |
1/2012 | Nyra Medical | Grant | 25k |
7/2017 | NanoV Therapeutics | Grant | 24.8k |
1/2019 | Migra Therapeutics | Grant | 51.7k |
9/2008 | Inhibikase Therapeutics | Grant | 25k |
8/2016 | CellectCell | Grant | - |
10/2015 | CellectCell | Grant | - |
7/2010 | Inhibikase Therapeutics | Grant | 150k |
11/2008 | Inhibikase Therapeutics | Grant | 25k |
12/2019 | Focused Cryo | Grant | 0 |
11/2017 | Covanos | Grant | 39k |
12/2015 | Covanos | Grant | 80.5k |
3/2018 | Covanos | Grant | 40k |
6/2016 | MicroBplex | Grant | 100k |
2/2018 | Cognition Medical | Grant | 84k |
5/2014 | MicroBplex | Grant | 73k |
7/2012 | MicroBplex | Grant | 25k |
9/2014 | RSV NewCo | Grant | 50k |
1/2016 | Codoxo | Grant | 0 |
7/2010 | Iconic Therapeutics | Grant | 100k |
3/2014 | Abby Med | Grant | 34k |
3/2016 | Sequegenics | Grant | 47.5k |
12/2016 | Neurotrack | Grant | 800k |
11/2015 | Accuitis | Seed Round | 0 |
7/2018 | BioPace | Grant | 105.2k |
9/2017 | MicroBplex | Grant | 50.7k |
3/2018 | Migra Therapeutics | Grant | 35.8k |
4/2010 | Iconic Therapeutics | Grant | 150k |
1/2010 | Iconic Therapeutics | Grant | 50k |
7/2012 | Sanguina | Grant | 25k |
7/2019 | Kodikaz Therapeutic Solutions | Grant | 50k |
1/2020 | BioData Consortium | Grant | 20k |
4/2017 | Corami Therapeutics | Grant | 29.9k |
5/2015 | Corami Therapeutics | Grant | 11.8k |
7/2019 | BioData Consortium | Grant | 25k |
7/2019 | Lucid Scientific | Grant | 58.5k |
10/2017 | Corami Therapeutics | Grant | 41.9k |
3/2017 | Sequegenics | Grant | 65k |
9/2011 | Inhibikase Therapeutics | Grant | 100k |
8/2009 | Iconic Therapeutics | Grant | 48k |
9/2017 | Reservoir | Grant | 25k |
7/2015 | QUE Oncology | Grant | 150k |
3/2016 | Sanguina | Grant | 81k |
11/2015 | QUE Oncology | Grant | 100k |
9/2006 | Velocity Medical Solutions | Grant | 50k |
12/2016 | NatGlycan | Grant | 25k |
6/2018 | Lucid Scientific | Grant | 23.9k |
1/2011 | AKESOgen | Grant | 50k |
7/2012 | Metaclipse Therapeutics | Grant | 57.5k |
4/2012 | Metaclipse Therapeutics | Grant | 42k |
11/2010 | Metaclipse Therapeutics | Grant | 25k |
6/2011 | LiquidText | Grant | - |
6/2016 | DIASYST Inc. | Grant | 50k |
9/2006 | NeurOp | Grant | 25k |
6/2017 | Covanos | Grant | 75k |
6/2018 | Oncospherix | Grant | 53.4k |
8/2021 | TendoNova | Seed Round | 250k |
9/2019 | TendoNova | Grant | 69k |
1/2019 | MapHabit | Grant | 48.4k |
10/2018 | MapHabit | Grant | 58.5k |
11/2013 | MedShape | Seed Round | - |
12/2008 | Velocity Medical Solutions | Grant | 150k |
1/2019 | DIASYST Inc. | Grant | 50k |
3/2020 | AngioCloud | Grant | 34.3k |
2/2022 | EarliTec Diagnostics | Series A | 19.5M |
5/2015 | MetCure Therapeutics | Grant | - |
7/2018 | PNP Therapeutics | Grant | 50k |
1/2018 | Celtaxsys | Series E | - |
2/2019 | Pyrefin | Grant | 48.1k |
7/2016 | RePredix | Grant | 44k |
8/2009 | Inhibikase Therapeutics | Grant | 50k |
6/2017 | BioPace | Grant | 30.3k |
3/2019 | Abby Med | Grant | 50.6k |
1/2016 | Corami Therapeutics | Grant | 58.2k |
11/2008 | Inhibikase Therapeutics | Grant | 55.6k |
10/2014 | Abby Med | Grant | 110k |
4/2012 | Cambium Medical Technologies | Grant | 25k |
2/2019 | Cognition Medical | Grant | 66k |
1/2019 | Neovaccine Strategies | Grant | 50k |
1/2011 | Whisper Communications | Grant | 48k |
1/2018 | Centizyme | Grant | 35.2k |
7/2014 | CloudTags | Grant | 15k |
9/2013 | QUE Oncology | Grant | 119k |
2/2013 | QUE Oncology | Grant | 25k |
10/2012 | QUE Oncology | Grant | 25k |
7/2014 | QUE Oncology | Grant | 98.9k |
5/2017 | Nutrivert | Grant | 23.8k |
5/2014 | NovAb | Grant | 50k |
12/2012 | NovAb | Grant | 25k |
11/2010 | NeurOp | Grant | 150k |
3/2005 | NeurOp | Grant | 50k |
10/2011 | NeurOp | Grant | 100k |
9/2017 | NatGlycan | Grant | 25k |
11/2015 | TendoNova | Grant | 49.3k |
8/2017 | TendoNova | Grant | 43.6k |
3/2019 | TendoNova | Grant | 36k |
3/2019 | Sequegenics | Grant | 32.5k |
5/2014 | Cambium Medical Technologies | Grant | 60k |
7/2007 | Velocity Medical Solutions | Grant | 100k |
1/2007 | Velocity Medical Solutions | Grant | 50k |
12/2005 | Velocity Medical Solutions | Grant | 50k |
7/2016 | MoQuality | Grant | 275k |
10/2011 | Cambium Medical Technologies | Grant | 25k |
3/2017 | DIASYST Inc. | Grant | 50k |
3/2014 | Sanguina | Grant | 25k |
2/2019 | Lucid Scientific | Grant | 26.4k |
4/2016 | NovAb | Grant | 100k |
5/2018 | PDx Scan | Grant | 17.5k |
5/2017 | Sanguina | Grant | 61k |
2/2013 | Sanguina | Grant | 13k |
1/2015 | CloudTags | Grant | 75k |
4/2016 | Nyra Medical | Grant | 20k |
7/2014 | Nyra Medical | Grant | 52.3k |
2/2011 | AKESOgen | Grant | 50k |
10/2011 | AKESOgen | Grant | 100k |
9/2014 | AlphaStem | Grant | 82.7k |
7/2012 | AlphaStem | Grant | 4k |
3/2016 | DIASYST Inc. | Grant | 50k |
4/2009 | NeurOp | Grant | 50k |
4/2015 | LymphaTech | Seed Round | - |
1/2012 | AKESOgen | Grant | 150k |
9/2013 | Behavioral Science Technologies | Grant | 22.8k |
10/2011 | Nyra Medical | Grant | 10k |
12/2014 | NovAb | Grant | 150k |
4/2012 | NovAb | Grant | 25k |
3/2018 | RePredix | Grant | 36k |
3/2020 | Aviabiotic | Grant | 0 |
8/2005 | NeurOp | Grant | 50k |
8/2018 | Centizyme | Grant | 10k |
12/2016 | Covanos | Grant | 49.9k |
10/2017 | Abby Med | Grant | 40.6k |
3/2017 | Urjanet | Series C | 0 |
11/2022 | Nyra Medical | Series A | 20M |
10/2009 | Inhibikase Therapeutics | Grant | 50k |
9/2014 | Clearside Biomedical | Series B | 16M |
8/2019 | HAWA Therapeutics | Seed Round | 25k |
11/2022 | Nyra Medical | Series A | 0 |
11/2018 | Antios Therapeutics | Series A | 0 |
2/2022 | EarliTec Diagnostics | Series A | 0 |
3/2020 | Aviabiotic | Grant | 0 |
3/2020 | AngioCloud | Grant | 0 |
3/2020 | Neovaccine Strategies | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
1/2020 | Nyra Medical | Grant | 0 |
1/2020 | BioData Consortium | Grant | 0 |
12/2019 | Focused Cryo | Grant | 0 |
11/2019 | PNP Therapeutics | Grant | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|